| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ARS Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 40K | Jun 20, 2024 | Direct | ||
| Longboard Pharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 22.5K | May 23, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| SPRY | ARS Pharmaceuticals, Inc. | Jun 20, 2024 | 1 | $0 | 4 | Jun 24, 2024 | Director |
| LBPH | Longboard Pharmaceuticals, Inc. | May 23, 2024 | 1 | $0 | 4 | May 24, 2024 | Director |
| SPRY | ARS Pharmaceuticals, Inc. | Jun 27, 2023 | 1 | $0 | 4 | Jun 28, 2023 | Director |
| LBPH | Longboard Pharmaceuticals, Inc. | May 25, 2023 | 1 | $0 | 4 | May 26, 2023 | Director |
| SPRY | ARS Pharmaceuticals, Inc. | Nov 8, 2022 | 2 | $0 | 4 | Nov 10, 2022 | Director |
| SPRY | ARS Pharmaceuticals, Inc. | Nov 8, 2022 | 0 | $0 | 3 | Nov 10, 2022 | Director |
| LBPH | Longboard Pharmaceuticals, Inc. | May 24, 2022 | 1 | $0 | 4 | May 31, 2022 | Director |